Semi-Annual Statement Of Income And Retained Earnings

BrightPath Biotherapeutics Co., Ltd. - Filing #7580403

Concept 2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2019-04-01 to
2020-03-31
2019-04-01 to
2020-03-31
2019-04-01 to
2020-03-31
2019-04-01 to
2020-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,732,802,000 JPY
-1,827,349,000 JPY
Non-operating income
Non-operating income
3,265,000 JPY
3,409,000 JPY
Non-operating expenses
Non-operating expenses
9,099,000 JPY
56,000 JPY
Ordinary profit (loss)
-1,738,636,000 JPY
-1,823,996,000 JPY
Extraordinary income
Extraordinary income
31,051,000 JPY
12,550,000 JPY
Extraordinary losses
Extraordinary losses
9,629,000 JPY
48,415,000 JPY
Profit (loss) before income taxes
-1,717,214,000 JPY
-1,859,861,000 JPY
Income taxes - current
2,420,000 JPY
2,732,000 JPY
Income taxes - deferred
JPY
-4,819,000 JPY
Profit (loss)
-1,719,634,000 JPY
-1,719,634,000 JPY
-1,719,634,000 JPY
-1,719,634,000 JPY
-1,857,774,000 JPY
-1,857,774,000 JPY
-1,857,774,000 JPY
-1,857,774,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.